Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
MedTech
FDA OKs Lumicell system for highlighting residual breast cancer
Lumisight was approved via the FDA’s drug review pathway while the visualization system took a parallel track through the agency's device center.
Conor Hale
Apr 19, 2024 11:08am
AACR: AstraZeneca PARP inhibitor gives 'bang for your buck'
Apr 9, 2024 5:00am
Could immunotherapy prevent breast cancer before it starts?
Apr 1, 2024 8:50am
FDA issues alert over risks with Hologic breast marker implant
Feb 28, 2024 10:35am
AstraZeneca places next ADC bet on in-house pipeline
Feb 21, 2024 8:00am
Pfizer funnels $15M into 3-year cancer care disparity initiative
Feb 5, 2024 10:00am